Cosgrove CA, Avanesov A, Rust D, Osibajo S, et al. A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults. Clin Infect Dis 2026 Apr 25:ciag278. doi: 10.1093.
PMID: 42033146